The European Commission will also sign a contract for a corona vaccine with the American manufacturer Moderna. This increases the chance that Germany will also receive a large number of cans quickly.
Europeans are also getting the corona vaccine from the American manufacturer Moderna, which is considered to be very promising. The European Commission has negotiated a framework agreement for up to 160 million cans, as announced by Commission head Ursula von der Leyen. The contract will be formally sealed on Wednesday.
The European Commission now has contracts with the manufacturers of all three vaccines, which will have the best chance of rapid approval in the coming weeks. Besides Moderna, these are Biontech / Pfizer and Astrazeneca. All three had announced promising test data in recent days. Accordingly, all three vaccines are effective and well tolerated.
First approvals in December?
No corona vaccine has yet been approved in Europe. The federal government and the European Commission expect the first permits to be issued in December. However, this requires an investigation by the European Medicines Agency (EMA).
The moderna vaccine that has now been ordered has an effectiveness of 94.5 percent, according to the manufacturer. The EMA has started a so-called ongoing assessment process for the preparation, the aim of which is to obtain approval relatively quickly.
The EU Commission concludes framework agreements with manufacturers on behalf of the 27 Member States. These contracts include advance payments so that the pharmaceutical companies can set up production quickly and first refusal rights for the EU states. Once a product is approved, all 27 states should have access to it at the same time, albeit only in small quantities initially, depending on production capacity.
Entitled to 18.6 percent of the cans
They are distributed in the EU based on population size. Germany has a share of 18.6 percent. In Germany, by contrast, according to the will of the federal government, risk groups and health workers must first be vaccinated. It will likely be months before everyone has a chance to get a protective kick.
Brussels has secured a wide variety of vaccines during development, even with the expectation that not all of them would work properly. However, if hopes for the promising vaccines are fulfilled, the EU will eventually have more than enough units for all approximately 450 million inhabitants, even though the vaccines usually have to be given twice.
In addition to Moderna’s 160 million cans, the European Commission has secured up to 300 million cans from Biontech / Pfizer and an additional 300 million cans from Astrazeneca. There are also other contracts with manufacturers that are not that far in development: up to 405 million cans from the German manufacturer Curevac, up to 300 million cans from Sanofi-GSK and up to 200 million cans from Johnson & Johnson.